Results 31 to 40 of about 41,992 (300)

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination [PDF]

open access: yes, 2017
Remyelination is in the center of new therapies for the treatment of multiple sclerosis to resolve and improve disease symptoms and protect axons from further damage.
Bramlett   +38 more
core   +1 more source

Induced Stem Cells as a Novel Multiple Sclerosis Therapy. [PDF]

open access: yes, 2016
Stem cell replacement is providing hope for many degenerative diseases that lack effective therapeutic methods including multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. Transplantation of neural stem cells or
Guan, Yang-Tai   +3 more
core   +2 more sources

Brain region dependent molecular signatures and myelin repair following chronic demyelination

open access: yesFrontiers in Cellular Neuroscience, 2023
Multiple sclerosis (MS) is the most prevalent demyelinating disease of the central nervous system, characterized by myelin destruction, axonal degeneration, and progressive loss of neurological functions.
Grace Samtani   +8 more
doaj   +1 more source

Gpr126/Adgrg6 has Schwann cell autonomous and nonautonomous functions in peripheral nerve injury and repair [PDF]

open access: yes, 2016
Schwann cells (SCs) are essential for proper peripheral nerve development and repair, although the mechanisms regulating these processes are incompletely understood.
Carlin, Dan   +8 more
core   +2 more sources

Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination

open access: yesNeurobiology of Disease, 2008
Osteopontin (OPN) is a key immunoregulator in the autoimmune-mediated demyelinating disease multiple sclerosis. OPN may also play a role in the remyelination since it is 1) a ligand for αV integrins, several of which regulate the properties of the ...
Chao Zhao   +3 more
doaj   +1 more source

Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model

open access: yesInternational Journal of Molecular Sciences, 2022
Remyelination therapies, which are currently under development, have a great potential to delay, prevent or even reverse disability in multiple sclerosis patients.
Heinig Leo, M. Kipp
semanticscholar   +1 more source

Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. [PDF]

open access: yes, 2011
Permanent damage to white matter tracts, comprising axons and myelinating oligodendrocytes, is an important component of brain injuries of the newborn that cause cerebral palsy and cognitive disabilities, as well as multiple sclerosis in adults. However,
Baranzini, Sergio E   +11 more
core   +3 more sources

Klotho pathways, myelination disorders, neurodegenerative diseases, and epigenetic drugs [PDF]

open access: yes, 2020
In this review we outline a rationale for identifying neuroprotectants aimed at inducing endogenous Klotho activity and expression, which is epigenetic action, by definition. Such an approach should promote remyelination and/or stimulate myelin repair by
Chen, Xiaohong   +15 more
core   +1 more source

Mechanisms involved in the remyelinating effect of sildenafil [PDF]

open access: yes, 2018
Remyelination occurs in demyelinated lesions in multiple sclerosis (MS) and pharmacological treatments that enhance this process will critically impact the long term functional outcome in the disease.
Díaz-Lucena, Daniela   +5 more
core   +1 more source

Microglia-neuron interaction at nodes of Ranvier depends on neuronal activity through potassium release and contributes to remyelination

open access: yesNature Communications, 2021
Microglia, the resident immune cells of the central nervous system, are key players in healthy brain homeostasis and plasticity. In neurological diseases, such as Multiple Sclerosis, activated microglia either promote tissue damage or favor ...
R. Ronzano   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy